BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michaud V, Tran M, Pronovost B, Bouchard P, Bilodeau S, Alain K, Vadnais B, Franco M, Bélanger F, Turgeon J. Impact of GSTA1 Polymorphisms on Busulfan Oral Clearance in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation. Pharmaceutics 2019;11:E440. [PMID: 31480560 DOI: 10.3390/pharmaceutics11090440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoudi A, Butler AE, Majeed M, Banach M, Sahebkar A. Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis. Nutrients 2022;14:1331. [PMID: 35405942 DOI: 10.3390/nu14071331] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Teslenko I, Watson CJW, Xia Z, Chen G, Lazarus P. Characterization of Cytosolic Glutathione S-Transferases Involved in the Metabolism of the Aromatase Inhibitor, Exemestane. Drug Metab Dispos 2021;49:1047-55. [PMID: 34593616 DOI: 10.1124/dmd.121.000635] [Reference Citation Analysis]
3 Matos A, Dow P, Bingham JM, Michaud V, Lesko LJ, Knowlton CH, Turgeon J. Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research. Pharmacogenomics 2021;22:731-5. [PMID: 34284600 DOI: 10.2217/pgs-2021-0085] [Reference Citation Analysis]
4 Yuan J, Sun N, Feng X, He H, Mei D, Zhu G, Zhao L. Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations. Pharmgenomics Pers Med 2021;14:253-68. [PMID: 33623415 DOI: 10.2147/PGPM.S289834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Michaud V, Turgeon J. Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy. Pharmaceutics 2021;13:197. [PMID: 33540658 DOI: 10.3390/pharmaceutics13020197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Buratti FM, Darney K, Vichi S, Turco L, Di Consiglio E, Lautz LS, Béchaux C, Dorne JCM, Testai E. Human variability in glutathione-S-transferase activities, tissue distribution and major polymorphic variants: Meta-analysis and implication for chemical risk assessment. Toxicol Lett 2021;337:78-90. [PMID: 33189831 DOI: 10.1016/j.toxlet.2020.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Martínez-Guzmán C, Cortés-Reynosa P, Pérez-Salazar E, Murillo-González FE, Elizondo G. Activation of the Aryl Hydrocarbon Receptor (AHR) induces human glutathione S transferase alpha 1 (hGSTA1) expression. Chem Biol Interact 2020;331:109284. [PMID: 33035518 DOI: 10.1016/j.cbi.2020.109284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sun Y, Huang J, Hao C, Li Z, Liang W, Zhang W, Chen B, Yang W, Hu J. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation. Cancer Chemother Pharmacol 2020;85:293-308. [PMID: 31834435 DOI: 10.1007/s00280-019-04001-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]